Available to sourceHuman Prescription DrugGastrointestinal

PRISMASOL

Active ingredients · Anhydrous Dextrose, Calcium Chloride, Lactic Acid, Magnesium Chloride, Potassium Chloride, Sodium Bicarbonate, Sodium Chloride

20 g/L / 5.15 g/L / 5.4 g/L / 2.03 g/L / .157 g/L / 3.09 g/L / 6.46 g/L · Injection

By Vantive US Healthcare LLC

NDC: 24571-103
Route: Intravenous
Therapeutic class: Acidifying Activity [MoA], Blood Coagulation Factor , Calcium [CS], Calculi Dissolution Agent , Cations, Divalent [CS], Increased Coagulation Factor Activity [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative , Osmotic Laxative , Osmotic Laxative , Osmotic Laxative , Phosphate Binder , Phosphate Chelating Activity [MoA], Potassium Compounds [CS], Potassium Salt , Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]
Marketing category: NDA

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.